211 related articles for article (PubMed ID: 35262978)
61. The safety of plasma apheresis from donors recovering from COVID-19 infection in Japan.
Kamo-Imai A; Togano T; Sato M; Kawakami Y; Inaba K; Shimazu H; Igarashi S; Tanaka K; Terada M; Kinoshita-Iwamoto N; Saito S; Kutsuna S; Hangaishi A; Morioka S; Takahashi K; Miyata S; Ohmagari N
Transfus Apher Sci; 2023 Jun; 62(3):103687. PubMed ID: 36964059
[TBL] [Abstract][Full Text] [Related]
62. Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial.
Soto A; Krapp F; Vargas A; Cabrejos L; Argumanis E; García PL; Altamirano K; Montes M; Chacón-Uscamaita PR; García PJ
Trials; 2021 May; 22(1):342. PubMed ID: 34001174
[TBL] [Abstract][Full Text] [Related]
63. Supplemental findings of the 2019 National Blood Collection and Utilization Survey.
Mowla SJ; Sapiano MRP; Jones JM; Berger JJ; Basavaraju SV
Transfusion; 2021 Sep; 61 Suppl 2(Suppl 2):S11-S35. PubMed ID: 34337759
[TBL] [Abstract][Full Text] [Related]
64. COVID-19 impact on Nigeria's national blood service commission - Lessons for Low- and Middle-Income Countries (LMICs).
Oreh AC; Irechukwu C; Biyama F; Nnabuihe A; Ihimekpen A; Oshiame D; Bozegha T; Leo-Nnadi I; Izedonmwen O; Oga E; Suberu EJ; Odiabara K; Amedu OJ
Niger Postgrad Med J; 2022; 29(1):6-12. PubMed ID: 35102944
[TBL] [Abstract][Full Text] [Related]
65. Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.
Hartmann J; Klein HG
Transfusion; 2020 Nov; 60(11):2748-2752. PubMed ID: 32856742
[No Abstract] [Full Text] [Related]
66. Blood group O convalescent plasma donations have significantly lower levels of SARS-CoV-2 IgG antibodies compared to blood group A donations.
Hayes C; Rubenstein W; Gibb D; Klapper E; Tanaka J; Pepkowitz S
Transfusion; 2021 Aug; 61(8):2245-2249. PubMed ID: 34036595
[TBL] [Abstract][Full Text] [Related]
67. Patient blood management and blood conservation - Complimentary concepts and solutions for blood establishments and clinical services in South Africa and beyond.
Rambiritch V; Verburgh E; Louw VJ
Transfus Apher Sci; 2021 Aug; 60(4):103207. PubMed ID: 34353706
[TBL] [Abstract][Full Text] [Related]
68. Mitigating the impact of blood shortages in England.
Chowdhury F; Estcourt L; Murphy MF
Br J Haematol; 2024 May; 204(5):1660-1671. PubMed ID: 38419589
[TBL] [Abstract][Full Text] [Related]
69. The impact of COVID-19 on blood safety and availability in the Islamic Republic of Iran.
Divkolaye N; Arabkhazaeli A; Hajibeigi B; Eshghi P
East Mediterr Health J; 2022 Nov; 28(11):823-828. PubMed ID: 36515446
[TBL] [Abstract][Full Text] [Related]
70. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
[TBL] [Abstract][Full Text] [Related]
71. Impact of Covid-19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes.
Quaglietta A; Nicolucci A; Posata R; Frattari A; Parruti G; Accorsi P
Transfus Med; 2021 Jun; 31(3):160-166. PubMed ID: 33269544
[TBL] [Abstract][Full Text] [Related]
72. Variant of Concern-Matched COVID-19 Convalescent Plasma Usage in Seronegative Hospitalized Patients.
Franchini M; Focosi D; Percivalle E; Beccaria M; Garuti M; Arar O; Pecoriello A; Spreafico F; Greco G; Bertacco S; Ghirardini M; Santini T; Schiavulli M; Stefania M; Gagliardo T; Sammartino JC; Ferrari A; Zani M; Ballotari A; Glingani C; Baldanti F
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891421
[TBL] [Abstract][Full Text] [Related]
73. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
[TBL] [Abstract][Full Text] [Related]
74. Blood component utilization in COVID-19 patients in New York City: Transfusions do not follow the curve.
DeSimone RA; Costa VA; Kane K; Sepulveda JL; Ellsworth GB; Gulick RM; Zucker J; Sobieszcyk ME; Schwartz J; Cushing MM
Transfusion; 2021 Mar; 61(3):692-698. PubMed ID: 33215718
[TBL] [Abstract][Full Text] [Related]
75. Management of blood transfusion services in low-resource countries.
Patidar GK; Thachil J; Dhiman Y; Oreh A; Vrielink H; van den Berg K; Grubovic Rastvorceva RM; So-Osman C; Al-Riyami AZ;
Vox Sang; 2022 Dec; 117(12):1375-1383. PubMed ID: 36349461
[TBL] [Abstract][Full Text] [Related]
76. Management of blood supply and demand during the COVID-19 pandemic in King Abdullah Hospital, Bisha, Saudi Arabia.
Yahia AIO
Transfus Apher Sci; 2020 Oct; 59(5):102836. PubMed ID: 32522473
[TBL] [Abstract][Full Text] [Related]
77. A critical contribution in a time of crisis: Examining motivations and deterrents to COVID-19 convalescent plasma donation and future donation intentions among prospective Canadian donors.
Holloway K; Campbell C; Ali R; Huyer LD; Hart D; Haw J; Brennenstuhl S; Grundy Q
Transfus Med; 2022 Oct; 32(5):351-365. PubMed ID: 35578828
[TBL] [Abstract][Full Text] [Related]
78. Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial.
Chowdhury FR; Hoque A; Chowdhury FUH; Amin MR; Rahim A; Rahman MM; Yasmin R; Amin MR; Miah MT; Kalam MA; Rahman MS
Trials; 2020 Oct; 21(1):883. PubMed ID: 33106167
[TBL] [Abstract][Full Text] [Related]
79. Qualifying coronavirus disease 2019 convalescent plasma donors in Israel.
Izak M; Gendelman V; Bransburg-Zabary S; Stoyanov E; Gat R; Cohen D; Chen J; Maor Y; Benov A; Lev B; Zimhony O; Shinar E
Vox Sang; 2022 Feb; 117(2):185-192. PubMed ID: 34125976
[TBL] [Abstract][Full Text] [Related]
80. The effect of the COVID-19 pandemic on the adequacy of blood supply: Specialists in transfusion medicine need to establish models of preparedness.
Rouka E
Transfus Apher Sci; 2021 Feb; 60(1):102960. PubMed ID: 33032919
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
